Biophotonic Composition Enhances Ultra-Weak Photon Emission

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack the ability to modulate the production and emission of ultra-weak photons by living organisms, which are spontaneously emitted but not controllable, limiting their application in monitoring and influencing biological energy states.

Innovation Solution

The use of biophotonic compositions that, when applied topically and stimulated with light, increase in-situ energy production and emission in biological tissues by incorporating light-accepting molecules that absorb light and emit fluorescence, enhancing metabolic activities and sustaining energy emission post-stimulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If spontaneous ultra-weak photon emission is observed in living organisms, then metabolic processes can be monitored non-invasively, but the emission intensity is too weak (10^-16-10^-18 W/cm2) to be detected by human eye and requires sensitive equipment

Engineering Contradiction:
Improvedetection sensitivityVSAvoidphoton emission intensity
Core Design Contradiction:
Measurement precisionVSIllumination intensity

Solution Approach 1:

The patent introduces biophotonic compositions containing light-accepting molecules as intermediaries between the external light source and the biological tissue. These molecules absorb light at specific wavelengths and transfer energy to enhance ultra-weak photon emission from metabolic processes, acting as a mediator that amplifies the weak signal while maintaining non-invasive monitoring capabilities

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies parameter changes by using specific wavelengths of light (e.g., 405 nm, 480 nm, 530 nm, 630 nm) to stimulate the biophotonic composition, which then enhances photon emission at different intensity levels. This allows modulation of the emission parameters to achieve detectable levels while maintaining the metabolic monitoring function

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If no methods exist to modulate ultra-weak photon production, then the natural metabolic state is preserved, but the ability to influence and control biological energy states is limited

Engineering Contradiction:
Improvemodulation capabilityVSAvoidnatural state stability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent implements dynamics by creating a controllable system where the biophotonic composition can be applied or removed, and the light stimulation can be adjusted in intensity and duration. This allows dynamic modulation of photon emission and metabolic activity while maintaining the ability to return to the natural state, providing both adaptability and reliability

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent uses parameter changes in the form of specific light wavelengths, intensities, and exposure times to modulate the biophotonic composition's effect on tissue. This enables controlled influence on metabolic processes while maintaining the option to restore natural conditions, achieving both versatility and stability

Inventive Principle:
Principle #35Parameter changes

3Productivity

If biophotonic compositions with light-accepting molecules are applied topically and stimulated with light, then in-situ energy production and emission are increased, but the complexity of the system increases

Engineering Contradiction:
Improveenergy production rateVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies universality by using biophotonic compositions that can work with multiple types of biological tissues (skin, muscle, organs) and multiple wavelengths of light. The same basic composition and stimulation approach can enhance energy production across different applications, reducing the need for complex specialized systems for each tissue type

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The biophotonic composition acts as a simplified intermediary that consolidates multiple functions: it contains light-accepting molecules for energy absorption, facilitates energy transfer to metabolic processes, and enhances photon emission. This single intermediary component simplifies the overall system compared to using multiple separate devices or procedures

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The biophotonic compositions significantly enhance and prolong the emission of ultra-weak photons from biological tissues, indicating increased metabolic activities and sustained energy production, as demonstrated by increased photon emission intensity and duration in experiments with pig and human skin.

Implementation Method 1

incorporating light-accepting molecules that absorb light

Methodology Applied
Scientific EffectAbsorption (EM radiation): Absorption (EM radiation)

Implementation Method 2

emit fluorescence, enhancing metabolic activities

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 3

Organisms are known to emit spontaneous ultra-weak photons which are differentiated from the phenomenon of delayed luminescence as it is spontaneously emitted by living organisms

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Implementation Method 4

The phenomenon of ultra-weak photon emission reflects metabolic processes

Methodology Applied
Scientific EffectChemiluminescence: Chemiluminescence

Data Source

PatentUS11953493B2Biophotonic methods for increasing in situ energy production and energy emission in biological cells and tissues
Publication Date: 2024.04.09 FLE INTERNATIONAL SRL
  • US11953493B2 patent drawing
  • US11953493B2 patent drawing
  • US11953493B2 patent drawing

AI summary

The present technology generally relates to a method for modulating in situ production of energy by a biological tissue. The method comprises stimulating the biological tissue by exposing the biological tissue to a photostimulated biophotonic composition for a time sufficient to initiate the production of energy by the biological tissue.